SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 26th, 2018 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 26, 2018, between Generex Biotechnology Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
STOCK PLEDGE AGREEMENTStock Pledge Agreement • October 26th, 2018 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
THIS STOCK PLEDGE AGREEMENT (this “Agreement”), dated as of October 26, 2018, by and between Joseph Moscato (“Pledgor”) and Alpha Capital Anstalt (“Pledgee”);
NOTE DUE OCTOBER 26, 2019Generex Biotechnology Corp • October 26th, 2018 • Pharmaceutical preparations • New York
THIS NOTE is one of a series of duly authorized and validly issued Notes of Generex Biotechnology Corporation, a Delaware corporation, (the “Borrower”), having its principal place of business at 4145 North Service Road, Suite 200, Burlington, Ontario, Canada L7L 6A3, email: mfletcher@generex.com, due October 26, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
